Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jeffrey Skolnik
Children's Oncology Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
38 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Princess Margaret Hospital for Children
Perth, Western Australia, Australia
- Hospital Sainte-Justine
Montreal, Quebec, Canada
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- Miller Children'S Hospital
Long Beach, California, United States
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Childrens Hospital of Orange County
Orange, California, United States
- Rady Children'S Hospital - San Diego
San Diego, California, United States
- University of California San Francisco Medical Center-Parnassus
San Francisco, California, United States
- Connecticut Children'S Medical Center
Hartford, Connecticut, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- Nemours Children'S Clinic - Jacksonville
Jacksonville, Florida, United States
- Nemours Childrens Clinic - Orlando
Orlando, Florida, United States
- Saint Joseph Children'S Hospital of Tampa
Tampa, Florida, United States
- Childrens Memorial Hospital
Chicago, Illinois, United States
- University of Illinois
Chicago, Illinois, United States
- Advocate Hope Children'S Hospital
Oak Lawn, Illinois, United States
- Indiana University Medical Center
Indianapolis, Indiana, United States
- Kosair Children'S Hospital
Louisville, Kentucky, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- C S Mott Children'S Hospital
Ann Arbor, Michigan, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Columbia University Medical Center
New York, New York, United States
- Mission Hospitals Inc
Asheville, North Carolina, United States
- Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- Rainbow Babies and Childrens Hospital
Cleveland, Ohio, United States
- Oregon Health and Science University
Portland, Oregon, United States
- Children'S Hospital of Pittsburgh of Upmc
Pittsburgh, Pennsylvania, United States
- Rhode Island Hospital
Providence, Rhode Island, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- East Tennessee Childrens Hospital
Knoxville, Tennessee, United States
- St. Jude Children'S Research Hospital
Memphis, Tennessee, United States
- Driscoll Children'S Hospital
Corpus Christi, Texas, United States
- University of Texas Southwestern Medical Center
Dallas, Texas, United States
- Baylor College of Medicine
Houston, Texas, United States
- Methodist Children'S Hospital of South Texas
San Antonio, Texas, United States
- Seattle Children'S Hospital
Seattle, Washington, United States
- Midwest Children'S Cancer Center
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Feb 2008
- Primary completion
- 30 Jun 2016
- Completion
- —
- Last update posted
- 17 May 2017
- Registered enrollment
- 158
- Registry id
- NCT00674193
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.